Results 191 to 200 of about 51,722 (241)
Some of the next articles are maybe not open access.
Diabetes Care, 1993
OBJECTIVE To determine an effective screening procedure for microalbuminuria. RESEARCH DESIGN AND METHODS The prevalence of microalbuminuria in NIDDM patients whose urine was negative on routine Albustix testing was studied.
M M, Bashyam +4 more
openaire +2 more sources
OBJECTIVE To determine an effective screening procedure for microalbuminuria. RESEARCH DESIGN AND METHODS The prevalence of microalbuminuria in NIDDM patients whose urine was negative on routine Albustix testing was studied.
M M, Bashyam +4 more
openaire +2 more sources
cclm, 1998
Abstract Microalbuminuria is still the only early abnormality of the diabetic kidney that has an established prognostic value. Microalbuminuria evolves into clinical nephropathy and renal failure in a majority of cases of insulin-dependent diabetic patients, and is defined by the detection of urinary albumin excretion rates of 20–200 μg ...
openaire +2 more sources
Abstract Microalbuminuria is still the only early abnormality of the diabetic kidney that has an established prognostic value. Microalbuminuria evolves into clinical nephropathy and renal failure in a majority of cases of insulin-dependent diabetic patients, and is defined by the detection of urinary albumin excretion rates of 20–200 μg ...
openaire +2 more sources
Is Microalbuminuria a Disease?
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012Debate has arisen as to the proper timing of starting angiotensin-converting enzyme (ACE) inhibitor or angiotensin II receptor blocker (ARB) therapy to mitigate nephropathy in patients with diabetes mellitus. In April 2012, an article published in both the Pharmacist’s Letter and the Prescriber’s Letter advocated the withholding of these therapies in ...
openaire +2 more sources
+Microalbuminuria in hypertension
Current Hypertension Reports, 2003A body of evidence indicates that microalbuminuria is a well-recognized marker of cardiovascular complications and increased cardiovascular risk in hypertension. However, the prognostic significance of microalbuminuria remains controversial because only the results of a few prospective studies performed in small groups of hypertensive subjects without ...
openaire +2 more sources
Simplified Screening for Microalbuminuria
Annals of Internal Medicine, 1997Screening for microalbuminuria is increasingly advocated as a way to diagnose early renal involvement in diabetes and other diseases. It usually entails the use of a radioimmunoassay that is expensive and not always readily available.To assess the efficacy of three simple and inexpensive tests for ruling out microalbuminuria.Cross-sectional study ...
A, Pegoraro +4 more
openaire +2 more sources
1998
Microalbuminuria, the abnormal urinary excretion of albumin, is recognised as an important independent marker of both renal and cardiovascular disease, particularly in diabetes mellitus. This volume is the only comprehensive and up-to-date review of the relevance of microalbuminuria to health and disease.
Peter H. Winocour, Sally M. Marshall
openaire +1 more source
Microalbuminuria, the abnormal urinary excretion of albumin, is recognised as an important independent marker of both renal and cardiovascular disease, particularly in diabetes mellitus. This volume is the only comprehensive and up-to-date review of the relevance of microalbuminuria to health and disease.
Peter H. Winocour, Sally M. Marshall
openaire +1 more source
Microalbuminuria and hypertension.
Minerva medica, 2005An elevated urinary albumin excretion (UAE) below the proteinuric level, i.e. microalbuminuria (MAU), has long been recognized as a marker of kidney disease and increased cardiovascular risk in both types of diabetes mellitus. Subsequent clinical evidence documented an association between MAU and other cardiovascular risk factors, target organ damage ...
REBOLDI, Gianpaolo +3 more
openaire +3 more sources
Kidney International, 2014
Drug efficacy is ascertained using clinically meaningful outcomes that directly affect the well-being of patients. However, in studies of chronic kidney disease progression, clinically meaningful outcomes like end-stage renal disease take a long time to occur.
Roscioni, Sara S. +2 more
openaire +1 more source
Drug efficacy is ascertained using clinically meaningful outcomes that directly affect the well-being of patients. However, in studies of chronic kidney disease progression, clinically meaningful outcomes like end-stage renal disease take a long time to occur.
Roscioni, Sara S. +2 more
openaire +1 more source
Prognostic Significance of Microalbuminuria
American Journal of Hypertension, 1994Diabetic nephropathy is the only increasing cause of renal failure in the Western world. It affects a large proportion of both insulin-dependent (IDDM) and non-insulin-dependent diabetic (NIDDM) patients. A critical stage in the development of diabetic renal disease is the onset of microalbuminuria, defined as an albumin excretion rate of 30 to 300 mg ...
openaire +2 more sources